Technology and Code

Published on 13 Oct 2022

Automated multimodal fluorescence microscopy for hyperplex spatial-proteomics: Coupling microfluidic-based immunofluorescence to high resolution, high sensitivity, three-dimensional analysis of histological slides

in Cancer Molecular Targets and Therapeutics

Laura Furia
Simone Pelicci
Federica Perillo
Maddalena M. Bolognesi
Pier Giuseppe Pelicci
Federica Facciotti
Giorgio Cattoretti
Mario Faretta

Frontiers in Oncology

doi 10.3389/fonc.2022.960734

3,089 views
6 citations

Original Research

Published on 13 Oct 2022

The antihyperlipidemic drug potassium piperonate impairs the migration and tumorigenesis of breast cancer cells via the upregulation of miR-31

in Cancer Molecular Targets and Therapeutics

Xiaoxia Tian
Junping Lu
Kathleen Nanding
Linzhe Zhang
Yanrong Liu
Mailisu Mailisu
Morigen Morigen
Lifei Fan

Frontiers in Oncology

doi 10.3389/fonc.2022.828160

1,796 views

Original Research

Published on 13 Oct 2022

CircHADHA-augmented autophagy suppresses tumor growth of colon cancer by regulating autophagy-related gene via miR-361

in Cancer Molecular Targets and Therapeutics

Ying Shi
Jinying Li
Ming Tang
Jingwen Liu
Yalu Zhong
Wei Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.937209

1,841 views
3 citations

Original Research

Published on 12 Oct 2022

Dual inhibition of BET and HAT/p300 suppresses colorectal cancer via DR5- and p53/PUMA-mediated cell death

in Cancer Molecular Targets and Therapeutics

Chaoyuan Kuang
Jingshan Tong
Kaylee Ermine
Manbo Cai
Fujun Dai
Suisui Hao
Francis Giles
Yi Huang
Jian Yu
Lin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1018775

2,384 views
6 citations

Correction

Published on 11 Oct 2022

Corrigendum: Dihydrocapsaicin inhibits cell proliferation and metastasis in melanoma via down-regulating β-catenin pathway

in Cancer Molecular Targets and Therapeutics

Shaomin Shi
Chongyang Li
Yanli Zhang
Chaowei Deng
Wei Liu
Juan Du
Qian Li
Yacong Ji
Leiyang Guo
Lichao Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.1052365

1,166 views

Mini Review

Published on 10 Oct 2022

Targeting aldehyde dehydrogenase for prostate cancer therapies

in Cancer Molecular Targets and Therapeutics

Miao Ma
Wenyou He
Keyu Zhao
Linyuan Xue
Siyuan Xia
Baotong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1006340

3,495 views
2 citations

Original Research

Published on 06 Oct 2022

Molecular and clinicopathological characteristics of ERBB2 gene fusions in 32,131 Chinese patients with solid tumors

in Cancer Molecular Targets and Therapeutics

Yin Guan
Yutong Wang
Hongxia Li
Jing Meng
Xia You
Xiaofeng Zhu
Qin Zhang
Tingting Sun
Chuang Qi
Guangyu An

Frontiers in Oncology

doi 10.3389/fonc.2022.986674

4,731 views
5 citations

Original Research

Published on 06 Oct 2022

CAPRIN2 upregulation by LINC00941 promotes nasopharyngeal carcinoma ferroptosis resistance and metastatic colonization through HMGCR

in Cancer Molecular Targets and Therapeutics

Lin Qiu
Rui Zhou
Ling Zhou
Shiping Yang
Jiangxue Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.931749

2,377 views
7 citations

Original Research

Published on 06 Oct 2022

Ferroptosis-related gene signature predicts prognosis in kidney renal papillary cell carcinoma

in Cancer Molecular Targets and Therapeutics

Haiying Yin
Mei Lin
Shaoying Liang
Meijuan Wei
Cuiting Huang
Fengfei Qin
Jiejin Nong
Xianchang Zeng
Caimei Nong
Houji Qin

Frontiers in Oncology

doi 10.3389/fonc.2022.988867

3,013 views
2 citations

Original Research

Published on 05 Oct 2022

Novel compound C150 inhibits pancreatic cancer through induction of ER stress and proteosome assembly

in Cancer Molecular Targets and Therapeutics

Tao Wang
Ping Chen
Scott Weir
Michael Baltezor
Frank J. Schoenen
Qi Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.870473

1,889 views
1 citation

Systematic Review

Published on 03 Oct 2022

Tryptophan 2,3-dioxygenase may be a potential prognostic biomarker and immunotherapy target in cancer: A meta-analysis and bioinformatics analysis

in Cancer Molecular Targets and Therapeutics

Yanyan Hu
Zhongjian Liu
Hui Tang

Frontiers in Oncology

doi 10.3389/fonc.2022.977640

2,565 views
7 citations

Original Research

Published on 03 Oct 2022

Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model

in Cancer Molecular Targets and Therapeutics

Kevin Hollevoet
Debby Thomas
Griet Compernolle
Giles Vermeire
Elien De Smidt
Stéphanie De Vleeschauwer
Trevor R. F. Smith
Paul D. Fisher
Maarten Dewilde
Nick Geukens

Frontiers in Oncology

doi 10.3389/fonc.2022.1017612

1,983 views
5 citations

Original Research

Published on 30 Sep 2022

ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway

in Cancer Molecular Targets and Therapeutics

Xin Wen
Si Chen
Xueting Chen
Hui Qiu
Wei Wang
Nie Zhang
Wanming Liu
Tingting Wang
Xin Ding
Longzhen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.887068

2,746 views
8 citations

Review

Published on 29 Sep 2022

Clinical applications of circulating tumor-derived DNA in the management of gastrointestinal cancers – current evidence and future directions

in Cancer Molecular Targets and Therapeutics

Rachel C. T. Lam
David Johnson
Gigi Lam
Michelle L. Y. Li
Joyce W. L. Wong
W. K. Jacky Lam
K. C. Allen Chan
Brigette Ma

Frontiers in Oncology

doi 10.3389/fonc.2022.970242

5,064 views
2 citations

Systematic Review

Published on 29 Sep 2022

The prognostic value of fibrinogen to albumin ratio in malignant tumor patients: A meta-analysis

in Cancer Molecular Targets and Therapeutics

Baibei Li
Huachu Deng
Biao Lei
Leijie Chen
Xinyuan Zhang
Dingran Sha

Frontiers in Oncology

doi 10.3389/fonc.2022.985377

1,776 views
13 citations

Original Research

Published on 29 Sep 2022

MiR-21 and let-7 cooperation in the regulation of lung cancer

in Cancer Molecular Targets and Therapeutics

Jinquan Bai
Zhenzhou Shi
Shuting Wang
Hong Pan
Tong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.950043

2,436 views
9 citations

Navigation group

Articles

Automated multimodal fluorescence microscopy for hyperplex spatial-proteomics: Coupling microfluidic-based immunofluorescence to high resolution, high sensitivity, three-dimensional analysis of histological slides

The antihyperlipidemic drug potassium piperonate impairs the migration and tumorigenesis of breast cancer cells via the upregulation of miR-31

CircHADHA-augmented autophagy suppresses tumor growth of colon cancer by regulating autophagy-related gene via miR-361

Dual inhibition of BET and HAT/p300 suppresses colorectal cancer via DR5- and p53/PUMA-mediated cell death

Corrigendum: Dihydrocapsaicin inhibits cell proliferation and metastasis in melanoma via down-regulating β-catenin pathway

Targeting aldehyde dehydrogenase for prostate cancer therapies

Molecular and clinicopathological characteristics of ERBB2 gene fusions in 32,131 Chinese patients with solid tumors

CAPRIN2 upregulation by LINC00941 promotes nasopharyngeal carcinoma ferroptosis resistance and metastatic colonization through HMGCR

Ferroptosis-related gene signature predicts prognosis in kidney renal papillary cell carcinoma

Novel compound C150 inhibits pancreatic cancer through induction of ER stress and proteosome assembly

Tryptophan 2,3-dioxygenase may be a potential prognostic biomarker and immunotherapy target in cancer: A meta-analysis and bioinformatics analysis

Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model

ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway

Clinical applications of circulating tumor-derived DNA in the management of gastrointestinal cancers – current evidence and future directions

The prognostic value of fibrinogen to albumin ratio in malignant tumor patients: A meta-analysis

MiR-21 and let-7 cooperation in the regulation of lung cancer